NCT01457833.
Trial name or title | Implantation of endobronchial valves versus intrabronchial valves in patients with severe heterogeneous emphysema |
Methods | Randomized open‐label study. Follow‐up: until 6 months. Estimated enrolment: n = 50 Site: Thoraxklink Heidelberg (Germany) |
Participants | COPD patients with severe heterogeneous emphysema Inclusion criteria:
|
Interventions | Unilateral endobronchial valves versus intrabronchial valve placement |
Outcomes |
Primary: Improvement in pulmonary function (FEV1 and RV/TLC)
Secondary:
|
Starting date | August 2011 |
Contact information | Principal Investigator: Daniela Gompelmann, MD |
Notes | NCT01457833 |